Inflammatory and lipid-associated markers of cardiovascular diseases in children with first exacerbation of inflammatory bowel disease

Medical Science Monitor

Volumn 22, Issue , 2016, Pages 1534-1539

  Pac Kożuchowska, Elżbieta ^a   Krawiec, Paulina ^a   Mroczkowska Juchkiewicz, Agnieszka ^a   Pawłowska Kamieniak, Agnieszka ^a   Kominek, Katarzyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Atherosclerosis; Colitis, ulcerative; Crohn disease; Inflammatory bowel diseases

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; MALE; NUTRITIONAL STATUS; PANCOLITIS; PROCTITIS; ULCERATIVE COLITIS; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; COMPLICATION; DISEASE COURSE; INFLAMMATION; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; BIOMARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; LIPIDS; MALE;

EID: 84968867158     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.896116     Document Type: Article

References (31)

1. Libby P, Ridker PM, Hansson GK: Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol, 2009; 54: 2129-38
2. Avina-Zubieta JA, Thomas J, Sadatsafavi M et al: Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis, 2012; 71: 1524-29
3. Patel RV, Shelling ML, Prodanovich S et al: Psoriasis and vascular diseaserisk factors and outcomes: a systematic review of the literature. J Gen Intern Med, 2011; 26: 1036-49
4. Cervera R, Khamashta MA, Font J et al: Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore), 2003; 82: 299-308
5. Principi M, Mastrolonardo M, Scicchitano P et al: Endothelial function and cardiovascular risk in active inflammatory bowel diseases. J Crohns Colitis, 2013; 7: e427-33
6. Hatoum OA, Spinelli KS, Abu-Hajir M et al: esenteric venous thrombosis in inflammatory bowel disease. J Clin Gastroenterol, 2005; 39: 27-31
7. Kim A, Jung BH, Cadet P: A novel pathway by which the environmental toxin 4-Nonylphenol may promote an inflammatory response in inflammatory bowel disease. Med Sci Monit Basic Res, 2014; 20: 47-54
8. Bernstein CN, Blanchard JF, Houston DS et al: The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost, 2001; 85: 430-34
9. Papa A, Danese S, Urgesi R et al: Early atherosclerosis in patients with inflammatory bowel disease. Eur Rev Med Pharmacol Sci, 2006; 10: 7-11
10. Aloi M, Tromba L, Di Nardo G et al: Premature subclinical atherosclerosis in pediatric inflammatory bowel disease. J Pediatr, 2012; 161: 589-94
11. Yarur AJ, Deshpande AR, Pechman DM et al: Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol, 2011; 106: 741-47
12. Dagli N, Poyrazoglu OK, Dagli AF et al: Is inflammatory bowel disease a risk factor for early atherosclerosis? Angiology, 2010; 61: 198-204
13. Broide E, Schopan A, Zaretsky M et al: Intima-media thickness of the common carotid artery is not significantly higher in Crohn’s disease patients compared to healthy population. Dig Dis Sci, 2011; 56: 197-202
14. Dorn SD, Sandler RS: Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol, 2007; 102: 662-67
15. Maharshak N, Arbel Y, Bornstein NM et al: Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol, 2007; 102: 1050-55
16. Spagnoli LG, Bonanno E, Sangiorgi G et al: Role of inflammation in atherosclerosis. J Nucl Med, 2007; 48: 1800-15
17. Inflammatory Bowel Disease in Children and Adolescents: Recommendations for Diagnosis-The Porto Criteria IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr, 2005; 41: 1-7
18. Libby P, Theroux P: Pathophysiology of coronary artery disease. Circulation, 2005; 111: 3481-88
19. Weber C, Noels H: Atherosclerosis: current pathogenesis and therapeutic options. Nat Med, 2011; 17: 1410-22
20. Singh RB, Mengi SA, Xu YJ et al: Pathogenesis of atherosclerosis: A multifactorial process. Exp Clin Cardiol, 2002; 7: 40-53
21. Szmitko PE, Wang CH, Weisel RD et al: New markers of inflammation and endothelial cell activation: Part I. Circulation, 2003; 21: 1917-23
22. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation, 2002; 105: 1135-43
23. Verma S, Wang CH, Li SH et al: A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation, 2002; 106: 913-19
24. Dayuan L, Mehta JL: Oxidized LDL, a critical factor in atherogenesis. Cardiovasc Res, 2005; 68: 353-54
25. Sappati Biyyani RS, Putka BS, Mullen KD: Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease. J Clin Lipidol, 2010; 4: 478-82
26. Agouridis AP, Elisaf M, Milionis HJ: An overview of lipid abnormalities in patients with inflammatory bowel disease. Ann Gastroenterol, 2011; 24: 181-87
27. Levy E, Rizwan Y, Thibault L et al: Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr, 2000; 71: 807-15
28. Romanato G, Scarpa M, Angriman I et al: Plasma lipids and inflammation in active inflammatory bowel diseases. Aliment Pharmacol Ther, 2009; 29: 298-307
29. Grip O, Janciauskiene S, Lindgren S: Circulating monocytes and plasma inflammatory biomarkers in active Crohn’s disease: elevated oxidized lowdensity lipoprotein and the anti-inflammatory effect of atorvastatin. Inflamm Bowel Dis, 2004; 10: 193-200
30. Koutroubakis IE, Malliaraki N, Vardas E et al: Increased levels of lipoprotein (a) in Crohn’s disease: a relation to thrombosis? Eur J Gastroenterol Hepatol, 2001; 13: 1415-19
31. Singh S, Singh H, Loftus EV Jr et al: Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol, 2014; 12: 382-93